Cargando…
Carbohydrate antigen 125 predicts pulmonary congestion in patients with ST-segment elevation myocardial infarction
Carbohydrate antigen 125 (CA125) has long been used as an ovarian cancer biomarker. However, because it is not specific for ovarian cells, CA125 could also be used to monitor congestion and inflammation in heart disease. Acute heart failure (HF) is used to identify patients with a worse prognosis in...
Autores principales: | Falcão, F.J.A., Oliveira, F.R.A., Cantarelli, F., Cantarelli, R., Brito-Júnior, P., Lemos, H., Silva, P., Camboim, I., Freire, M.C., Carvalho, O., Sobral-Filho, D.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903802/ https://www.ncbi.nlm.nih.gov/pubmed/31826182 http://dx.doi.org/10.1590/1414-431X20199124 |
Ejemplares similares
-
Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction
por: Falcão, Felipe, et al.
Publicado: (2020) -
Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?
por: Feng, Rui, et al.
Publicado: (2023) -
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure
por: Kumric, Marko, et al.
Publicado: (2021) -
An overview of reviews: what do we know about task shifting and skill mix change in healthcare?
por: Meda, F, et al.
Publicado: (2023) -
One-Year Clinical Outcome of Inspiron Stent in All-Comers Population (Analysis from 790 Consecutive Patients)
por: Falcão, Felipe, et al.
Publicado: (2020)